Bank of America’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,329
Closed -$34K 7850
2021
Q1
$34K Sell
1,329
-2,859
-68% -$75K ﹤0.01% 6752
2020
Q4
$108K Sell
4,188
-1,048
-20% -$26.1K ﹤0.01% 5947
2020
Q3
$126K Sell
5,236
-502
-9% -$12K ﹤0.01% 5561
2020
Q2
$131K Buy
5,738
+2,738
+91% +$60.7K ﹤0.01% 5527
2020
Q1
$58K Buy
3,000
+100
+3% +$2.18K ﹤0.01% 5804
2019
Q4
$68K Buy
2,900
+300
+12% +$6.53K ﹤0.01% 6153
2019
Q3
$53K Buy
2,600
+500
+24% +$10.3K ﹤0.01% 6302
2019
Q2
$44K Hold
2,100
﹤0.01% 6351
2019
Q1
$45K Sell
2,100
-500
-19% -$10.4K ﹤0.01% 6235
2018
Q4
$50K Buy
2,600
+500
+24% +$10.7K ﹤0.01% 6216
2018
Q3
$49K Buy
2,100
+100
+5% +$2.32K ﹤0.01% 6220
2018
Q2
$43K Hold
2,000
﹤0.01% 6215
2018
Q1
$42K Sell
2,000
-7
-0.3% -$154 ﹤0.01% 6102
2017
Q4
$43K Hold
2,007
﹤0.01% 6127
2017
Q3
$40K Buy
+2,007
New +$40.5K ﹤0.01% 6024

Other funds holding FTXH

Bank of America's FTXH Position: Q2 2021 in Review

Bank of America sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q2 2021, closing a stake of 1,329 shares — an estimated $34K sold.

Bank of America first reported a position in FTXH in Q3 2017 and held it in 15 quarters. The position peaked at $131K in Q2 2020. 18 funds tracked by Wall St. Rank hold FTXH as of Q2 2021.

  • Bank of America reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
  • Bank of America sold 1,329 First Trust Nasdaq Pharmaceuticals ETF shares in Q2 2021, an estimated $34K.
  • Bank of America first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q3 2017 and held it in 15 quarters.
  • Bank of America's First Trust Nasdaq Pharmaceuticals ETF position peaked at $131K in Q2 2020.
  • 18 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q2 2021.

Based on Bank of America's 13F filing for Q2 2021, filed 16 Aug 2021.